BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17729388)

  • 21. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Chavez-Tapia NC; Mendez-Sanchez N; Uribe M
    Ann Intern Med; 2006 Mar; 144(5):379; author reply 380. PubMed ID: 16520485
    [No Abstract]   [Full Text] [Related]  

  • 22. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
    Kida Y; Sato T
    Ann Intern Med; 2006 Mar; 144(5):379-80; author reply 380. PubMed ID: 16520484
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonalcoholic Fatty liver disease.
    Jorgensen RA
    Gastroenterol Nurs; 2003; 26(4):150-4; quiz 154-5. PubMed ID: 12920429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
    Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
    Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease.
    Powell EE; Jonsson JR; Clouston AD
    Ann Intern Med; 2005 Nov; 143(10):753-4. PubMed ID: 16287799
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.
    Cortez-Pinto H; Machado M
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):217-31. PubMed ID: 19072357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease: Disease and comorbidity--effects on quality of life.
    Marchesini G; Bianchi G
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):504-6. PubMed ID: 19713981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidemiology and natural history of nonalcoholic fatty liver disease].
    Pais R; Ratziu V
    Rev Prat; 2012 Dec; 62(10):1416-8, 1420-1. PubMed ID: 23424924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease and liver transplantation.
    Angulo P
    Liver Transpl; 2006 Apr; 12(4):523-34. PubMed ID: 16555318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease.
    Adams LA; Lindor KD
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease as a component of the metabolic syndrome.
    Khashab MA; Liangpunsakul S; Chalasani N
    Curr Gastroenterol Rep; 2008 Feb; 10(1):73-80. PubMed ID: 18417046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
    Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Widhalm K; Ghods E
    Int J Obes (Lond); 2010 Oct; 34(10):1451-67. PubMed ID: 20838401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
    Carvalheira JB; Saad MJ
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease in pediatric patients.
    Sinatra FR
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):43S-8S. PubMed ID: 22237875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.